ViroGates A/S (CPH:VIRO)
Denmark · Delayed Price · Currency is DKK 10.10
-0.10 (-0.98%)
Sep 25, 2026, 12:29 PM CET
ViroGates Market Cap
ViroGates has a market cap or net worth of 93.75 million as of September 25, 2026. Its market cap has increased by 20.01% in one year.
Market Cap
93.75M
Enterprise Value
80.05M
Revenue
9.36M
Ranking
n/a
PE Ratio
n/a
Stock Price
10.10
ChartMarket Cap Chart
Since June 26, 2018, ViroGates's market cap has decreased from 259.22M to 93.75M, a decrease of -63.83%. That is a compound annual growth rate of -11.59%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 93.75M | -24.91% |
| Dec 30, 2025 | 124.84M | 52.27% |
| Dec 30, 2024 | 81.99M | 111.23% |
| Dec 29, 2023 | 38.81M | -71.09% |
| Dec 30, 2022 | 134.25M | -70.57% |
| Dec 30, 2021 | 456.12M | 79.21% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 26, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.12T |
| Genmab | 136.96B |
| Coloplast | 94.48B |
| Demant | 65.38B |
| Gubra | 5.02B |
| BioPorto | 547.10M |
| Pharma Equity Group | 89.61M |
| Scandinavian Medical Solutions | 67.01M |